| # | Drug | Count |
|---|---|---|
| 0 | RANITIDINE | 1644 |
| 1 | RANITIDINE HYDROCHLORIDE | 385 |
| 2 | ADALIMUMAB | 196 |
| 3 | ETANERCEPT | 189 |
| 4 | METHOTREXATE SODIUM | 173 |
| 5 | METHOTREXATE | 141 |
| 6 | INTERFERON BETA-1A | 138 |
| 7 | ERGOCALCIFEROL | 104 |
| 8 | INFLIXIMAB | 104 |
| 9 | LEVOTHYROXINE SODIUM | 102 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACETAMINOPHEN CHLORPHENIRAMINE MALEATE PHENYLEPHERINE HYDROCHLORIDE | 1 | 0.0233 |
| 1 | TOREMIFENE CITRATE | 10 | 0.0232 |
| 2 | ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE | 2 | 0.0152 |
| 3 | CHOLESTERINUM | 11 | 0.0098 |
| 4 | RANITIDINE | 1644 | 0.0083 |
| 5 | TRASTUZUMAB-DKST | 2 | 0.0073 |
| 6 | RANITIDINE HYDROCHLORIDE | 385 | 0.0071 |
| 7 | TAMOXIFEN CITRATE | 31 | 0.0054 |
| 8 | AMLODIPINE AND VALSARTAN | 1 | 0.0051 |
| 9 | DIMETHYL SULFOXIDE | 1 | 0.0041 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 347 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 219 |
| 2 | Corticosteroid [EPC] | 206 |
| 3 | Estrogen [EPC] | 150 |
| 4 | Interferon beta [EPC] | 142 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 141 |
| 6 | Insulin Analog [EPC] | 132 |
| 7 | Benzodiazepine [EPC] | 127 |
| 8 | Vitamin C [EPC] | 117 |
| 9 | Interleukin-23 Antagonist [EPC] | 114 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 14 | 0.0203 |
| 1 | Provitamin D2 Compound [EPC] | 104 | 0.0035 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 5 | 0.0024 |
| 3 | CD4-directed Blocking Antibody [EPC] | 1 | 0.0019 |
| 4 | alpha-Hydroxy Acid [EPC] | 3 | 0.0014 |
| 5 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 3 | 0.0013 |
| 6 | Progestin Antagonist [EPC] | 6 | 0.0013 |
| 7 | CD19-directed Cytolytic Antibody [EPC] | 1 | 0.0012 |
| 8 | Interleukin-17A Antagonist [EPC] | 42 | 0.0011 |
| 9 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |